Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Diagnosis: Survivorship Research for People Living with Advanced and Metastatic Cancers.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Engagement in Cancer Epidemiology Cohorts.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

The Paul Fearn Award for Excellence in Data Sharing in Cancer Control and Population Sciences.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Characterizing Survivors Living With Likely Incurable Cancer: A Closer Look at an Emerging Population.

JCO oncology practice·2025
Same author

Re-examining survivorship research for people living with advanced and metastatic cancers: A portfolio analysis update of National Institutes of Health-funded grants.

Journal of cancer survivorship : research and practice·2025
Same author

Prevalence of Rare Cancer Survivors in the United States.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025

Related Experiment Video

Updated: Mar 1, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.8K

Current Assessment of Existing Biospecimen Use in Population-Based Cancer Research.

Rachel Hanisch1,2, Lisa Gallicchio1, Danielle Daee1

  • 1Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.

Biopreservation and Biobanking
|February 28, 2026
PubMed
Summary

Researchers are increasingly using banked biospecimens for cancer research. Blood products, DNA, tissue, and RNA are common, with usage varying by cancer type and research focus (risk vs. survivorship).

Keywords:
biobankbiorepositorybiospecimencancercohortepidemiology

More Related Videos

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
06:42

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

668
Creation and Maintenance of a Living Biobank - How We Do It
13:08

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

8.2K

Related Experiment Videos

Last Updated: Mar 1, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.8K
Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
06:42

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

668
Creation and Maintenance of a Living Biobank - How We Do It
13:08

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

8.2K

Area of Science:

  • Oncology
  • Population Science
  • Biorepository Science

Background:

  • Biospecimens are crucial for linking biological data with clinical, social, and environmental factors in population-based cancer research.
  • Collecting and processing new biospecimens is resource-intensive, making existing, banked biospecimens a valuable alternative for researchers.
  • The National Cancer Institute (NCI) supports population-based cancer control research through various grants.

Purpose of the Study:

  • To analyze the utilization of existing biospecimens in NCI-funded cancer control research grants.
  • To understand patterns of biospecimen use across different cancer types and research objectives.
  • To assess the role of banked biospecimens in advancing cancer prevention, treatment, and survivorship research.

Main Methods:

  • A review of 104 NCI grants managed by the Division of Cancer Control and Population Sciences (DCCPS) that utilized existing biospecimens.
  • Data abstraction included cancer type, biospecimen type, study design (intervention/observational), cancer continuum (risk/etiology or survivorship), and biospecimen resource.
  • Analysis focused on identifying common biospecimen types and usage patterns.

Main Results:

  • Blood products (64.4%), DNA (59.6%), tissue (53.8%), and RNA (26.9%) were the most frequently used biospecimens.
  • Blood products were predominant in risk-focused studies, while tissue and RNA were more common in survivorship studies.
  • Rare cancer studies utilized tissue and RNA less frequently compared to studies of common cancers.

Conclusions:

  • The diverse application of biospecimens highlights their importance across the cancer research spectrum.
  • Banked biospecimens are essential for investigating hypotheses related to cancer risk and survivorship.
  • Continued utilization of biospecimen resources supports comprehensive cancer control research.